As expected, we found that the genes with increased expression in DCs in MG patients were enriched in antigen processing and presentation, cytokine-mediated signaling pathway, and TNF-alpha/nuclear factor k-light-chain-enhancer of activated B cells (Nf-kappa B) signaling (Fig. 5e). The gene discussed is TNF; the disease is myasthenia gravis.